Bourgeon Capital Management LLC Allogene Therapeutics, Inc. Transaction History

Bourgeon Capital Management LLC

  • $520 Million
  • Q3 2024

A detailed history of Bourgeon Capital Management LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Bourgeon Capital Management LLC holds 142,580 shares of ALLO stock, worth $266,624. This represents 0.08% of its overall portfolio holdings.

Number of Shares
142,580
Previous 132,455 7.64%
Holding current value
$266,624
Previous $308,000 29.55%
% of portfolio
0.08%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
BUY
$2.08 - $3.5 $21,060 - $35,437
10,125 Added 7.64%
142,580 $399,000
Q2 2024

Jul 11, 2024
BUY
$2.23 - $4.38 $167,818 - $329,616
75,255 Added 131.56%
132,455 $308,000
Q1 2024

Apr 19, 2024
BUY
$2.92 - $5.63 $18,980 - $36,595
6,500 Added 12.82%
57,200 $255,000
Q4 2023

Jan 30, 2024
SELL
$2.28 - $3.5 $25,079 - $38,500
-11,000 Reduced 17.83%
50,700 $162,000
Q3 2023

Nov 01, 2023
SELL
$3.17 - $5.96 $16,642 - $31,290
-5,250 Reduced 7.84%
61,700 $195,000
Q2 2023

Jul 20, 2023
BUY
$4.53 - $6.74 $176,670 - $262,860
39,000 Added 139.53%
66,950 $332,000
Q4 2022

Jan 20, 2023
BUY
$5.62 - $11.11 $95,540 - $188,870
17,000 Added 155.25%
27,950 $0
Q3 2022

Oct 27, 2022
SELL
$10.32 - $17.28 $217,236 - $363,744
-21,050 Reduced 65.78%
10,950 $118,000
Q2 2022

Jul 27, 2022
BUY
$6.78 - $12.28 $37,290 - $67,540
5,500 Added 20.75%
32,000 $365,000
Q1 2022

May 03, 2022
BUY
$7.65 - $15.29 $153,000 - $305,800
20,000 Added 307.69%
26,500 $241,000
Q4 2021

Jan 31, 2022
SELL
$13.13 - $24.52 $331,204 - $618,517
-25,225 Reduced 79.51%
6,500 $97,000
Q3 2021

Nov 09, 2021
SELL
$21.01 - $27.64 $33,090 - $43,533
-1,575 Reduced 4.73%
31,725 $815,000
Q2 2021

Jul 19, 2021
BUY
$23.49 - $35.8 $782,217 - $1.19 Million
33,300 New
33,300 $868,000
Q1 2021

May 13, 2021
SELL
$25.79 - $39.02 $514,510 - $778,449
-19,950 Closed
0 $0
Q4 2020

Jan 29, 2021
BUY
$25.24 - $43.45 $286,474 - $493,157
11,350 Added 131.98%
19,950 $504,000
Q3 2020

Oct 28, 2020
BUY
$32.38 - $44.96 $246,088 - $341,696
7,600 Added 760.0%
8,600 $324,000
Q2 2020

Jul 27, 2020
SELL
$18.39 - $54.04 $22,987 - $67,550
-1,250 Reduced 55.56%
1,000 $43,000
Q1 2020

May 07, 2020
BUY
$18.22 - $28.25 $18,220 - $28,250
1,000 Added 80.0%
2,250 $44,000
Q4 2019

Feb 04, 2020
BUY
$24.82 - $31.4 $31,025 - $39,250
1,250 New
1,250 $32,000

Others Institutions Holding ALLO

# of Institutions
163
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $269M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Bourgeon Capital Management LLC Portfolio

Follow Bourgeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bourgeon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email